Latest Trends and Innovations in Multiple Myeloma Management at EHA 2024
Updates in the treatment and management of multiple myeloma presented at the European Hematology Association 2024 Hybrid Congress are discussed by Joseph Mikael, MD.
Video content above is prompted by the following: What are the latest trends and innovations you have observed in the treatment and management of multiple myeloma (MM) leading up to the European Hematology Association 2024 Hybrid Congress (EHA2024)
Let’s begin with newly diagnosed MM (NDMM). How has the paradigm of NDMM management shifted recently?